GlassScriptPhysician profile
Kayla Praino
NPI 1174367791
$1,712.59
in general payments reported to CMS, 2019-2025
10 companies · $1,563 in 2025
The $1,563 reported for 2025 was more than what 88% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $150 · 2025: $1,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,027 · Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,027.37 |
| Food and Beverage | $685.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $626.40 | 2025 | |
| Polaris Technology Solutions LLC | $618.88 | 2025 | |
| Saluda Medical Americas, INC. | $151.11 | 2025 | Evoke |
| Amgen INC. | $94.36 | 2024-2025 | Evenity, Prolia, Prolia |
| Ferring Pharmaceuticals INC. | $80.10 | 2024-2025 | Euflexxa |
| Si-Bone, INC. | $40.02 | 2024 | |
| Spr Therapeutics, INC | $34.69 | 2025 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $26.33 | 2024 | Exparel |
| Bioventus LLC | $20.75 | 2025 | Gelsyn-3 |
| Globus Medical, INC. | $19.95 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Praino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.